Cochlear’s strong results as sales rebound
Hearing implant manufacturer Cochlear has revealed that sales jumped 19 per cent, or 16 percent in constant currency terms, in the year ended June to reach $1.96 billion. Sales were driven by the release of new products and as clinicians caught up with implant surgeries postponed during the Covid-19 pandemic. The company, which launched its…